Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00429858
Status:
TERMINATED
Last Update Posted:
2020-09-18
First Post:
2007-01-30
Brief Title:
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Sponsor:
Andrew Ko
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
06456
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Andrew Ko
Lead Sponsor Class:
OTHER
Responsible Party:
Andrew Ko
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of California San Francisco
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Taiho Pharmaceutical Co Ltd | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |